Total submissions: 16
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000124449 | SCV000167882 | benign | not specified | 2013-02-21 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001507242 | SCV000262161 | benign | Ehlers-Danlos syndrome, classic type, 1 | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000124449 | SCV000302208 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV002310685 | SCV000319453 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2015-03-02 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Illumina Laboratory Services, |
RCV000372978 | SCV000478568 | likely benign | Ehlers-Danlos syndrome type 7A | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000589919 | SCV000695396 | benign | not provided | 2017-03-10 | criteria provided, single submitter | clinical testing | Variant summary: The COL5A1 c.4135C>T (p.Pro1379Ser) variant involves the alteration of a conserved nucleotide, resulting in a missense substitution. 4/5 in silico tools predict a damaging outcome for this variant, however these predictions have yet to be confirmed by functional studies. This variant was found in 900/121304 control chromosomes (7 homozygotes) at a frequency of 0.0074194, which is approximately 5935 times the estimated maximal expected allele frequency of a pathogenic COL5A1 variant (0.0000013), suggesting this variant is likely a benign polymorphism. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as benign. Taken together, this variant is classified as benign. |
Eurofins Ntd Llc |
RCV000124449 | SCV000703175 | benign | not specified | 2016-11-22 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000589919 | SCV000883653 | benign | not provided | 2024-08-26 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000589919 | SCV002546120 | likely benign | not provided | 2025-02-01 | criteria provided, single submitter | clinical testing | COL5A1: BS2 |
Genome- |
RCV001507242 | SCV002554596 | benign | Ehlers-Danlos syndrome, classic type, 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002269893 | SCV002554597 | benign | Fibromuscular dysplasia, multifocal | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002277207 | SCV002565741 | benign | Ehlers-Danlos syndrome | 2022-05-27 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002498593 | SCV002812397 | benign | Ehlers-Danlos syndrome, classic type, 1; Fibromuscular dysplasia, multifocal | 2021-10-04 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000589919 | SCV005226594 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV000124449 | SCV001809232 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000124449 | SCV001931282 | benign | not specified | no assertion criteria provided | clinical testing |